| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 19 |
| 1 | ADALIMUMAB | 11 |
| 2 | CALCIUM | 6 |
| 3 | PANTOPRAZOLE | 6 |
| 4 | ANASTROZOLE | 5 |
| 5 | ANASTROZOLE TABLETS | 5 |
| 6 | ENZALUTAMIDE | 5 |
| 7 | RIBOCICLIB | 5 |
| 8 | ASPIRIN | 4 |
| 9 | ASPIRIN 325 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TESAMORELIN | 2 | 0.0012 |
| 1 | PRASTERONE | 2 | 0.0007 |
| 2 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| 3 | CYPROHEPTADINE HYDROCHLORIDE | 2 | 0.0004 |
| 4 | RESMETIROM | 1 | 0.0004 |
| 5 | RIFABUTIN | 1 | 0.0004 |
| 6 | ASFOTASE ALFA | 3 | 0.0003 |
| 7 | LEUPROLIDE ACETATE | 19 | 0.0002 |
| 8 | ANASTROZOLE TABLETS | 5 | 0.0002 |
| 9 | LANTHANUM CARBONATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 2 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 5 | Androgen [EPC] | 2 | 0.0001 |
| 6 | Androgen Receptor Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 2 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |